A close up of a person injecting a medication into their stomach
Popular weight loss medication tirzepatide, sold as Zepbound, will now be available at a steep discount from manufacturer Eli Lilly, in an attempt to fight back against cheap knock-off versions of the drug.
  • Eli Lilly is cutting the price of its popular weight-loss drug to compete with counterfeit weight-loss drugs.
  • Zepbound will be sold for $399-$549 per month, compared to a previous list price of $1,059.
  • It's a move to retake the market after high demand and shortages prompted a spike in off-brand options.

One of the biggest weight-loss drugs on the market will now be available at half the cost, as its manufacturer hopes to reclaim the market from booming counterfeit sales.